Copy Number Variations of Complement Component C4 Are Associated With Behçet's Disease but Not With Ankylosing Spondylitis Associated With Acute Anterior Uveitis
Shengping Hou
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorJian Qi
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorDan Liao
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorQi Zhang
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorJing Fang
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorYan Zhou
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorYunjia Liu
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorLin Bai
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorMeifen Zhang
Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorAize Kijlstra
University Eye Clinic Maastricht, Maastricht, Limburg, The Netherlands
Search for more papers by this authorCorresponding Author
Peizeng Yang
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
The First Affiliated Hospital of Chongqing Medical University, Youyi Road 1, Chongqing 400016, China. E-mail: [email protected]Search for more papers by this authorShengping Hou
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorJian Qi
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorDan Liao
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorQi Zhang
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorJing Fang
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorYan Zhou
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorYunjia Liu
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorLin Bai
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
Search for more papers by this authorMeifen Zhang
Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorAize Kijlstra
University Eye Clinic Maastricht, Maastricht, Limburg, The Netherlands
Search for more papers by this authorCorresponding Author
Peizeng Yang
The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China
The First Affiliated Hospital of Chongqing Medical University, Youyi Road 1, Chongqing 400016, China. E-mail: [email protected]Search for more papers by this authorAbstract
Objective
Complement component C4 copy number variations are associated with various inflammatory diseases. This study was undertaken to investigate whether copy number variations of C4 are also involved in the pathogenesis of Behçet's disease (BD).
Methods
Gene expression was examined by enzyme-linked immunosorbent assay (ELISA) or real-time polymerase chain reaction (PCR). Copy number variations of C4 isotypes (C4A and C4B) were detected by real-time PCR in 905 patients with BD, 205 patients with ankylosing spondylitis (AS) and acute anterior uveitis, and 1,238 controls. The activation of CD4+ T cells was analyzed by flow cytometry, and cytokine production was detected by ELISA.
Results
Protein expression of total C4 in serum was significantly increased in patients with active BD compared with those with inactive BD or controls (Bonferroni corrected P [Pcorr] = 1.64 × 10−4 and Pcorr = 0.037, respectively), but not in patients with AS and acute anterior uveitis. Copy number variation analysis identified a significantly increased frequency of more than 2 copies of C4A in BD patients (P = 1.65 × 10−7, odds ratio [OR] 2.84). HLA–B51, which is located on the same chromosome as C4, showed a strong association with BD in the Han Chinese population (P = 8.90 × 10−65, OR 5.05), but logistic regression showed that C4A copy number variation was an independent risk factor for BD. A significantly increased expression of C4A was observed in the high copy number groups (>2 copies or 2 copies) versus the low copy number group (Pcorr = 0.019 and Pcorr = 0.044, respectively). Increased production of interleukin-6 (IL-6) was also observed in the high C4A copy number group (Pcorr = 0.037). No effect of C4 copy number variation on the expression of T cell activation markers was detected.
Conclusion
Our findings indicate that a high copy number of C4A confers risk for BD by modulating the expression of C4A and enhancing IL-6 production.
REFERENCES
- 1Suttorp-Schulten MS, Rothova A.The possible impact of uveitis in blindness: a literature survey.Br J Ophthalmol1996; 80: 844–8.
- 2Chang JH, Wakefield D.Uveitis: a global perspective.Ocul Immunol Inflamm2002; 10: 263–79.
- 3Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S.Epidemiological survey of intraocular inflammation in Japan.Jpn J Ophthalmol2007; 51: 41–4.
- 4Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al.Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China.Curr Eye Res2005; 30: 943–8.
- 5Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A.Clinical features of Chinese patients with Behçet's disease.Ophthalmology2008; 115: 312–8.e4.
- 6Van der Heijde D, Machado P, Braun J, Hermann KG, Baraliakos X, Hsu B, et al.MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis.Ann Rheum Dis2012; 71: 369–73.
- 7Braun J, Sieper J.Ankylosing spondylitis.Lancet2007; 369: 1379–90.
- 8Jha P, Bora PS, Bora NS.The role of complement system in ocular diseases including uveitis and macular degeneration.Mol Immunol2007; 44: 3901–8.
- 9Jha P, Sohn JH, Xu Q, Nishihori H, Wang Y, Nishihori S, et al.The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.Invest Ophthalmol Vis Sci2006; 47: 1030–8.
- 10Bora NS, Jha P, Bora PS.The role of complement in ocular pathology.Semin Immunopathol2008; 30: 85–95.
- 11Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, et al.Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.Nat Genet2006; 38: 458–62.
- 12Kondo N, Bessho H, Honda S, Negi A.Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis.Ophthalmology2011; 118: 339–44.
- 13Tuo J, Grob S, Zhang K, Chan CC.Genetics of immunological and inflammatory components in age-related macular degeneration.Ocul Immunol Inflamm2012; 20: 27–36.
- 14Wakefield D, Buckley R, Golding J, McCluskey P, Abi-Hanna D, Charlesworth J, et al.Association of complement allotype C4B2 with anterior uveitis.Hum Immunol1988; 21: 233–7.
- 15Yang MM, Lai TY, Tam PO, Chiang SW, Ng TK, Liu K, et al.Association of C2 and CFB polymorphisms with anterior uveitis.Invest Ophthalmol Vis Sci2012; 53: 4969–74.
- 16Boteva L, Morris DL, Cortes-Hernandez J, Martin J, Vyse TJ, Fernando MM.Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.Am J Hum Genet2012; 90: 445–56.
- 17Lv Y, He S, Zhang Z, Li Y, Hu D, Zhu K, et al.Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population.Rheumatol Int2012; 32: 3047–53.
- 18Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, et al.Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.Am J Human Genet2007; 80: 1037–54.
- 19Rigby WF, Wu YL, Zan M, Zhou B, Rosengren S, Carlson C, et al.Increased frequency of complement C4B deficiency in rheumatoid arthritis.Arthritis Rheum2012; 64: 1338–44.
- 20Liu YH, Wan L, Chang CT, Liao WL, Chen WC, Tsai Y, et al.Association between copy number variation of complement component C4 and Graves' disease.J Biomed Sci2011; 18: 71.
- 21Uko G, Christiansen FT, Dawkins RL, McCann VJ.Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles.J Clin Pathol1986; 39: 573–6.
- 22Welch TR, Brickman C, Bishof N, Maringhini S, Rutkowski M, Frenzke M, et al.The phenotype of SLE associated with complete deficiency of complement isotype C4A.J Clin Immunol1998; 18: 48–51.
- 23Van Zeben D, Giphart MJ, Christiansen FT, Hoetjer M, Meyer EC, Breedveld FC.Properdin factor B and complement factor C4 allotypes in rheumatoid arthritis: results of a follow-up study.Hum Immunol1992; 33: 148–51.
- 24Gilliam BE, Wolff AE, Moore TL.Partial C4 deficiency in juvenile idiopathic arthritis patients.J Clin Rheumatol2007; 13: 256–60.
- 25 International Study Group for Behçet's Disease.Criteria for diagnosis of Behçet's disease [review].Lancet1990; 335: 1078–80.
- 26Van der Linden S, Valkenburg HA, Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria.Arthritis Rheum1984; 27: 361–8.
- 27Yabuki K, Ohno S, Mizuki N, Ando H, Tabbara KF, Goto K, et al.HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia.Tissue Antigens1999; 54: 273–7.
- 28Olerup O, Zetterquist H.HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.Tissue Antigens1992; 39: 225–35.
- 29Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P.Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet's disease susceptibility.Hum Genet2012; 131: 1841–50.
- 30Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, et al.Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study.Arthritis Rheum2012; 64: 4104–13.
- 31Grevink ME, Horst G, Limburg PC, Kallenberg CG, Bijl M.Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.J Autoimmun2005; 24: 329–36.
- 32Bardak Y, Aridogan BC.The demonstration of serum interleukin 6-8, tumor necrosis factor-α, complement, and immunoglobulin levels in Behçet's disease with ocular involvement.Ocul Immunol Inflamm2004; 12: 53–8.
- 33Gul A.Behçet's disease as an autoinflammatory disorder.Curr Drug Targets Inflamm Allergy2005; 4: 81–3.
- 34Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, et al.SUMO4 gene polymorphisms in Chinese Han patients with Behçet's disease.Clin Immunol2008; 129: 170–5.
- 35Chen Z, Koralov SB, Kelsoe G.Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.J Exp Med2000; 192: 1339–52.
- 36Zhou ZY, Chen SL, Shen N, Lu Y.Cytokines and Behçet's disease.Autoimmun Rev2012; 11: 699–704.
- 37Manderson AP, Botto M, Walport MJ.The role of complement in the development of systemic lupus erythematosus.Annu Review Immunol2004; 22: 431–56.
- 38Law SK, Dodds AW, Porter RR.A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.EMBO J1984; 3: 1819–23.
- 39Wetsel RA.Structure, function and cellular expression of complement anaphylatoxin receptors.Curr Opin Immunol1995; 7: 48–53.
- 40Tokoro Y, Seto T, Abe Y, Takahashi H, Takahashi Y.Skin lesions in Behçet's disease.Int J Dermatol1977; 16: 227–44.
- 41Yurdakul S, Hamuryudan V, Yazici H.Behçet syndrome.Curr Opin Rheumatol2004; 16: 38–42.
- 42Hauptmann G, Grosshans E, Heid E.Lupus erythematosus syndrome and complete deficiency of the fourth component of complement.Boll Ist Sieroter Milan1974; 53 Suppl: 228.
- 43Cook HT, Botto M.Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus.Nat Clin Pract Rheumatol2006; 2: 330–7.
- 44Steinberg JB, Kapelanski DP, Olson JD, Weiler JM.Cytokine and complement levels in patients undergoing cardiopulmonary bypass.J Thorac Cardiovasc Surg1993; 106: 1008–16.
- 45Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A.Acute phase proteins in major depression.J Psychosom Res1997; 43: 529–34.
- 46Tuzun E, Scott BG, Goluszko E, Higgs S, Christadoss P.Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.J Immunol2003; 171: 3847–54.
- 47Evereklioglu C, Er H, Turkoz Y, Cekmen M.Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.Mediators Inflamm2002; 11: 87–93.
- 48Horai R, Caspi RR.Cytokines in autoimmune uveitis.J Interferon Cytokine Res2011; 31: 733–44.
- 49Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, et al.Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.Exp Eye Research2010; 91: 162–70.
- 50Yoshimura T, Sonoda KH, Ohguro N, Ohsugi Y, Ishibashi T, Cua DJ, et al.Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.Rheumatology (Oxford)2009; 48: 347–54.
